LA JOLLA, Calif., September 2, 2025 – Enlaza Therapeutics, the first covalent biologics platform company, today announced a multi-target drug discovery collaboration with Vertex Pharmaceuticals (Nasdaq: VRTX) to utilize Enlaza’s...
Sean McCarthy will join a roundtable discussion of "How to Transform your Technology into a Sustainable Marketable Product" at the San Jose BioCenter.
News | 03. 22. 2007
